Glg Has Lowered Masco (MAS) Position; Immunogen (IMGN) Shorts Increased By 13.77%

January 18, 2018 - By Michael Collier

Glg Llc decreased Masco Corp (MAS) stake by 8.51% reported in 2017Q3 SEC filing. Glg Llc sold 7,868 shares as Masco Corp (MAS)’s stock rose 10.38%. The Glg Llc holds 84,627 shares with $3.30 million value, down from 92,495 last quarter. Masco Corp now has $14.55B valuation. The stock increased 0.94% or $0.43 during the last trading session, reaching $46.26. About 2.35M shares traded. Masco Corporation (NYSE:MAS) has risen 18.02% since January 18, 2017 and is uptrending. It has outperformed by 1.32% the S&P500.

Immunogen Incorporated (NASDAQ:IMGN) had an increase of 13.77% in short interest. IMGN’s SI was 13.09 million shares in January as released by FINRA. Its up 13.77% from 11.50 million shares previously. With 2.42 million avg volume, 5 days are for Immunogen Incorporated (NASDAQ:IMGN)’s short sellers to cover IMGN’s short positions. The stock decreased 3.03% or $0.25 during the last trading session, reaching $8.01. About 2.13M shares traded. ImmunoGen, Inc. (NASDAQ:IMGN) has declined 3.49% since January 18, 2017 and is downtrending. It has underperformed by 20.19% the S&P500.

Investors sentiment decreased to 0.98 in 2017 Q3. Its down 0.08, from 1.06 in 2017Q2. It worsened, as 49 investors sold MAS shares while 180 reduced holdings. 60 funds opened positions while 165 raised stakes. 275.40 million shares or 0.11% more from 275.10 million shares in 2017Q2 were reported. Moreover, Grp Inc has 0.02% invested in Masco Corporation (NYSE:MAS). Principal Financial Group Inc accumulated 0.02% or 619,353 shares. Winslow Evans Crocker Inc stated it has 246 shares or 0% of all its holdings. Montag A Associates has 0.52% invested in Masco Corporation (NYSE:MAS) for 123,551 shares. Third Avenue Mgmt Limited Liability Co holds 556,045 shares or 0.98% of its portfolio. Buffington Mohr Mcneal reported 81,405 shares. Bp Public Ltd Liability Com has 106,000 shares for 0.15% of their portfolio. Lpl Financial Ltd Com stated it has 71,472 shares or 0.01% of all its holdings. Seizert Prtn Ltd Liability Corporation holds 0.02% of its portfolio in Masco Corporation (NYSE:MAS) for 11,683 shares. 42,674 were reported by Bollard Gp Limited Company. Winfield Assocs Inc holds 478 shares or 0.01% of its portfolio. 159 are held by Hudock Group Ltd Liability. Verition Fund Management Ltd Liability invested 0.08% in Masco Corporation (NYSE:MAS). Howe & Rusling Inc invested in 125 shares or 0% of the stock. Boston Advsrs Limited Liability Company holds 0.02% or 27,360 shares.

Since August 3, 2017, it had 0 buys, and 5 selling transactions for $3.69 million activity. O’Reagan Richard A. also sold $744,410 worth of Masco Corporation (NYSE:MAS) shares. Another trade for 52,511 shares valued at $2.09 million was made by Sznewajs John G on Friday, October 27. $682,254 worth of stock was sold by Lindow John P on Thursday, October 26. 2,266 shares were sold by Cole Kenneth G., worth $84,663. $87,708 worth of stock was sold by Gross Joseph B. on Friday, September 8.

Glg Llc increased Marvell Technology Group Ltd (NASDAQ:MRVL) stake by 273,395 shares to 339,412 valued at $6.08M in 2017Q3. It also upped Molina Healthcare Inc (Call) (NYSE:MOH) stake by 101,603 shares and now owns 124,000 shares. Texas Instrs Inc (NASDAQ:TXN) was raised too.

Analysts await Masco Corporation (NYSE:MAS) to report earnings on February, 8. They expect $0.43 earnings per share, up 30.30% or $0.10 from last year’s $0.33 per share. MAS’s profit will be $135.27M for 26.90 P/E if the $0.43 EPS becomes a reality. After $0.50 actual earnings per share reported by Masco Corporation for the previous quarter, Wall Street now forecasts -14.00% negative EPS growth.

Among 23 analysts covering Masco (NYSE:MAS), 13 have Buy rating, 0 Sell and 10 Hold. Therefore 57% are positive. Masco had 56 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Buy” rating by Evercore given on Monday, January 25. The stock has “Buy” rating by Jefferies on Wednesday, October 11. The stock of Masco Corporation (NYSE:MAS) earned “Overweight” rating by Barclays Capital on Thursday, April 7. The stock of Masco Corporation (NYSE:MAS) has “Buy” rating given on Wednesday, October 25 by RBC Capital Markets. The stock of Masco Corporation (NYSE:MAS) earned “Buy” rating by Argus Research on Thursday, October 26. Jefferies maintained the shares of MAS in report on Wednesday, May 31 with “Buy” rating. RBC Capital Markets maintained the shares of MAS in report on Wednesday, May 31 with “Buy” rating. The company was downgraded on Wednesday, October 25 by Wells Fargo. The stock of Masco Corporation (NYSE:MAS) earned “Buy” rating by RBC Capital Markets on Monday, October 9. Barclays Capital maintained the shares of MAS in report on Tuesday, October 13 with “Equal-Weight” rating.

ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company has market cap of $1.06 billion. The firm develops its products using its antibody-drug conjugate technology. It currently has negative earnings. The companyÂ’s product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha for the treatment of platinum-resistant ovarian cancer; IMGN529, an ADC that is in Phase 1b/2 clinical trials for B-cell malignancies; coltuximab ravtansine, which is in Phase 2 trials for B-cell malignancies; IMGN779 that is in Phase 1 clinical trials for the treatment of acute myeloid leukemia (AML); and IMGN632, a preclinical CD123-targeting ADC for the treatment of hematological malignancies, including AML.

Investors sentiment decreased to 1.16 in Q3 2017. Its down 0.04, from 1.2 in 2017Q2. It turned negative, as 16 investors sold ImmunoGen, Inc. shares while 48 reduced holdings. 38 funds opened positions while 36 raised stakes. 87.70 million shares or 19.45% more from 73.42 million shares in 2017Q2 were reported. Franklin Resource Inc holds 0.01% of its portfolio in ImmunoGen, Inc. (NASDAQ:IMGN) for 2.81M shares. Clearbridge Ltd holds 0.08% of its portfolio in ImmunoGen, Inc. (NASDAQ:IMGN) for 11.45 million shares. 703,892 were reported by Tiaa Cref Inv Mngmt Ltd. Ameritas Invest stated it has 6,651 shares or 0% of all its holdings. Jfs Wealth Limited Liability Corporation reported 0% in ImmunoGen, Inc. (NASDAQ:IMGN). Northwestern Mutual Wealth Mgmt Com has invested 0% in ImmunoGen, Inc. (NASDAQ:IMGN). Principal Finance Group Inc Inc Inc owns 13,054 shares. Gru Incorporated One Trading L P holds 0% in ImmunoGen, Inc. (NASDAQ:IMGN) or 21,233 shares. Macquarie Gp Limited invested in 0.01% or 850,000 shares. Moreover, Covington Cap Management has 0% invested in ImmunoGen, Inc. (NASDAQ:IMGN). 81,040 were reported by State Board Of Administration Of Florida Retirement. New York-based Baker Bros Advisors Ltd Partnership has invested 0.17% in ImmunoGen, Inc. (NASDAQ:IMGN). 590,708 are owned by Eam Investors Ltd Liability Corporation. Parametric Port Assoc Limited Liability Co reported 0% in ImmunoGen, Inc. (NASDAQ:IMGN). Lpl Ltd holds 0% of its portfolio in ImmunoGen, Inc. (NASDAQ:IMGN) for 51,776 shares.

Since September 13, 2017, it had 0 buys, and 2 insider sales for $262,957 activity. Berkenblit Anna sold $10,500 worth of stock. 37,050 ImmunoGen, Inc. (NASDAQ:IMGN) shares with value of $252,457 were sold by BARROWS CRAIG.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: